Anti-Mullerian hormone: A new actor of sexual dimorphism in pituitary gonadotrope activity before puberty

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Garrel, Ghislaine ^a,b,c   Racine, Chrystèle ^a,b,c   L'Hote, David ^a,b,c   Denoyelle, Chantal ^a,b,c   Guigon, Celine J ^a,b,c   Di Clemente, Nathalie ^a,b,c   Cohen Tannoudji, Joelle ^a,b,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Centre National pour la Recherche Scientifique   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; ANTI-MULLERIAN HORMONE RECEPTOR; BMP2 PROTEIN, RAT; BONE MORPHOGENETIC PROTEIN 2; FOLLITROPIN; GONADORELIN; LUTEINIZING HORMONE; MESSENGER RNA; MUELLERIAN INHIBITING FACTOR; RECEPTOR; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADENOHYPOPHYSIS; ANIMAL; CELL LINE; CYTOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GONADOTROPIN SECRETING CELL; GROWTH, DEVELOPMENT AND AGING; HYPOTHALAMUS; MALE; METABOLISM; NEWBORN; RAT; SECRETION (PROCESS); SEXUAL DEVELOPMENT; SEXUAL MATURATION; SIGNAL TRANSDUCTION; WISTAR RAT;

ACTIVINS; ANIMALS; ANIMALS, NEWBORN; ANTI-MULLERIAN HORMONE; BONE MORPHOGENETIC PROTEIN 2; CELL LINE; FEMALE; FOLLICLE STIMULATING HORMONE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GONADOTROPHS; GONADOTROPIN-RELEASING HORMONE; HYPOTHALAMUS; LUTEINIZING HORMONE; MALE; PITUITARY GLAND, ANTERIOR; RATS; RATS, WISTAR; RECEPTORS, PEPTIDE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; SEX CHARACTERISTICS; SEXUAL MATURATION; SIGNAL TRANSDUCTION; SMAD PROTEINS;

EID: 84962836355     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep23790     Document Type: Article

References (53)

1. Counis, R. et al. Gonadotropin-releasing hormone and the control of gonadotrope function. Reprod Nutr Dev 45, 243-254 (2005).
2. Bliss, S. P., Navratil, A. M., Xie, J., Roberson, M. S. GnRH signaling, the gonadotrope and endocrine control of fertility. Front Neuroendocrinol 31, 322-340 (2010).
3. Kim, T., Do, M. H., Lawson, M. A. Translational control of gene expression in the gonadotrope. Mol Cell Endocrinol 385, 78-87 (2014).
4. Thackray, V. G., Mellon, P. L., Coss, D. Hormones in synergy: regulation of the pituitary gonadotropin genes. Mol Cell Endocrinol 314, 192-203 (2010).
5. Winters, S. J., Moore, J. P. Intra-pituitary regulation of gonadotrophs in male rodents and primates. Reproduction 128, 13-23 (2004).
6. Attardi, B. et al. Rapid and profound suppression of messenger ribonucleic acid encoding follicle-stimulating hormone beta by inhibin from primate Sertoli cells. Mol Endocrinol 3, 280-287 (1989).
7. Lee, K. B. et al. Bone morphogenetic protein 2 and activin A synergistically stimulate follicle-stimulating hormone beta subunit transcription. J Mol Endocrinol 38, 315-330 (2007).
8. Weiss, J., Crowley, W. F. Jr., Halvorson, L. M., Jameson, J. L. Perifusion of rat pituitary cells with gonadotropin-releasing hormone, activin, and inhibin reveals distinct effects on gonadotropin gene expression and secretion. Endocrinology 132, 2307-2311 (1993).
9. Josso, N., Picard, J. Y., Rey, R., di Clemente, N. Testicular anti-Mullerian hormone: history, genetics, regulation and clinical applications. Pediatr Endocrinol Rev 3, 347-358 (2006).
10. Teixeira, J., Maheswaran, S., Donahoe, P. K. Mullerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications. Endocr Rev 22, 657-674 (2001).
11. Racine, C. et al. Receptors for anti-mullerian hormone on Leydig cells are responsible for its effects on steroidogenesis and cell differentiation. Proc Natl Acad Sci USA 95, 594-599 (1998).
12. Lee, M. M. et al. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab 81, 571-576 (1996).
13. Al-Attar, L. et al. Hormonal and cellular regulation of Sertoli cell anti-Mullerian hormone production in the postnatal mouse. J Clin Invest 100, 1335-1343 (1997).
14. Visser, J. A., de Jong, F. H., Laven, J. S., Themmen, A. P. Anti-Mullerian hormone: a new marker for ovarian function. Reproduction 131, 1-9 (2006).
15. La Marca, A. et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update 16, 113-130 (2010).
16. Bedecarrats, G. Y., O'Neill, F. H., Norwitz, E. R., Kaiser, U. B., Teixeira, J. Regulation of gonadotropin gene expression by Mullerian inhibiting substance. Proc Natl Acad Sci USA 100, 9348-9353 (2003).
17. Wang, P. Y. et al. Mullerian inhibiting substance acts as a motor neuron survival factor in vitro. Proc Natl Acad Sci USA 102, 16421-16425 (2005).
18. Lebeurrier, N. et al. Anti-Mullerian-hormone-dependent regulation of the brain serine-protease inhibitor neuroserpin. J Cell Sci 121, 3357-3365 (2008).
19. Poonlaphdecha, S. et al. Elevated amh gene expression in the brain of male tilapia (Oreochromis niloticus) during testis differentiation. Sex Dev 5, 33-47 (2011).
20. di Clemente, N. et al. Processing of anti-mullerian hormone regulates receptor activation by a mechanism distinct from TGF-beta. Mol Endocrinol 24, 2193-2206 (2010).
21. Bernard, D. J. Both SMAD2 and SMAD3 mediate activin-stimulated expression of the follicle-stimulating hormone beta subunit in mouse gonadotrope cells. Mol Endocrinol 18, 606-623 (2004).
22. Faure, E. et al. Mutant isoforms of the anti-Mullerian hormone type II receptor are not expressed at the cell membrane. J Biol Chem 271, 30571-30575 (1996).
23. Ojeda, S. R.,rews, W. W., Advis, J. P., White, S. S. Recent advances in the endocrinology of puberty. Endocr Rev 1, 228-257 (1980).
24. Stephen, A. E. et al. Highly purified mullerian inhibiting substance inhibits human ovarian cancer in vivo. Clin Cancer Res 8, 2640-2646 (2002).
25. Gupta, V. et al. Mullerian inhibiting substance suppresses tumor growth in the C3(1)T antigen transgenic mouse mammary carcinoma model. Proc Natl Acad Sci USA 102, 3219-3224 (2005).
26. Ojeda, S. R., Lomniczi, A. Puberty in 2013: Unravelling the mystery of puberty. Nat Rev Endocrinol 10, 67-69 (2014).
27. Durlinger, A. L. et al. Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary. Endocrinology 140, 5789-5796 (1999).
28. Pankhurst, M. W., McLennan, I. S. Human blood contains both the uncleaved precursor of anti-Mullerian hormone and a complex of the NH2-and COOH-terminal peptides. Am J Physiol Endocrinol Metab 305, E1241-1247 (2013).
29. Nachtigal, M. W., Ingraham, H. A. Bioactivation of Mullerian inhibiting substance during gonadal development by a kex2/subtilisin-like endoprotease. Proc Natl Acad Sci USA 93, 7711-7716 (1996).
30. Bernard, D. J., Fortin, J., Wang, Y., Lamba, P. Mechanisms of FSH synthesis: what we know, what we don't, and why you should care. Fertil Steril 93, 2465-2485 (2010).
31. Burger, L. L., Haisenleder, D. J., Dalkin, A. C., Marshall, J. C. Regulation of gonadotropin subunit gene transcription. J Mol Endocrinol 33, 559-584 (2004).
32. Dalkin, A. C., Haisenleder, D. J., Ortolano, G. A., Ellis, T. R., Marshall, J. C. The frequency of gonadotropin-releasing-hormone stimulation differentially regulates gonadotropin subunit messenger ribonucleic acid expression. Endocrinology 125, 917-924 (1989).
33. Lawson, M. A. et al. Pulse sensitivity of the luteinizing hormone beta promoter is determined by a negative feedback loop Involving early growth response-1 and Ngfi-A binding protein 1 and 2. Mol Endocrinol 21, 1175-1191 (2007).
34. Lim, S. et al. Negative feedback governs gonadotrope frequency-decoding of gonadotropin releasing hormone pulse-frequency. PLoS One 4, e7244 (2009).
35. Thompson, I. R., Kaiser, U. B. GnRH pulse frequency-dependent differential regulation of LH and FSH gene expression. Mol Cell Endocrinol 385, 28-35 (2014).
36. Bilezikjian, L. M., Justice, N. J., Blackler, A. N., Wiater, E., Vale, W. W. Cell-type specific modulation of pituitary cells by activin, inhibin and follistatin. Mol Cell Endocrinol 359, 43-52 (2012).
37. Attardi, B., Miklos, J. Rapid stimulatory effect of activin-A on messenger RNA encoding the follicle-stimulating hormone betasubunit in rat pituitary cell cultures. Mol Endocrinol 4, 721-726 (1990).
38. Massague, J., Seoane, J., Wotton, D. Smad transcription factors. Genes Dev 19, 2783-2810 (2005).
39. Baarends, W. M. et al. Anti-mullerian hormone and anti-mullerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology 136, 4951-4962 (1995).
40. Pierre, A. et al. Loss of LH-induced down-regulation of anti-Mullerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome. Hum Reprod 28, 762-769 (2013).
41. Mishina, Y. et al. Genetic analysis of the Mullerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes Dev 10, 2577-2587 (1996).
42. Debeljuk, L., Arimura, A., Schally, A. V. Studies on the pituitary responsiveness to luteinizing hormone-releasing hormone (LHRH) in intact male rats of different ages. Endocrinology 90, 585-588 (1972).
43. Debeljuk, L., Arimura, A., Schally, A. V. Pituitary responsiveness to LH-releasing hormone in intact female rats of different ages. Endocrinology 90, 1499-1502 (1972).
44. Potau, N., Ibanez, L., Sentis, M., Carrascosa, A. Sexual dimorphism in the maturation of the pituitary-gonadal axis, assessed by GnRH agonist challenge. Eur J Endocrinol 141, 27-34 (1999).
45. Wang, P. Y. et al. Mullerian inhibiting substance contributes to sex-linked biases in the brain and behavior. Proc Natl Acad Sci USA 106, 7203-7208 (2009).
46. Wittmann, W., McLennan, I. S. Anti-Mullerian hormone may regulate the number of calbindin-positive neurons in the sexually dimorphic nucleus of the preoptic area of male mice. Biol Sex Differ 4, 18 (2013).
47. Pepinsky, R. B. et al. Proteolytic processing of mullerian inhibiting substance produces a transforming growth factor-beta-like fragment. J Biol Chem 263, 18961-18964 (1988).
48. Pankhurst, M. W., Leathart, B. A., Batchelor, N. J., McLennan, I. S. The anti-Mullerian hormone precursor (proAMH) is not converted to the receptor-competent form (AMH) in the circulating blood of mice. Endocrinology, en20151834, doi: 10.1210/en.2015-1834 (2016).
49. Ooi, G. T., Tawadros, N., Escalona, R. M. Pituitary cell lines and their endocrine applications. Mol Cell Endocrinol 228, 1-21 (2004).
50. Brunet, N., Gourdji, D., Tixier-Vidal, A. Effect of 17 beta-estradiol on thyroliberin responsiveness in GH3/B6 rat prolactin cells. Mol Cell Endocrinol 18, 123-136 (1980).
51. Turgeon, J. L., Kimura, Y., Waring, D. W., Mellon, P. L. Steroid and pulsatile gonadotropin-releasing hormone (GnRH) regulation of luteinizing hormone and GnRH receptor in a novel gonadotrope cell line. Mol Endocrinol 10, 439-450 (1996).
52. Garrel, G. et al. Unsaturated fatty acids stimulate LH secretion via novel PKCepsilon and-theta in gonadotrope cells and inhibit GnRH-induced LH release. Endocrinology 152, 3905-3916 (2011).
53. Giton, F. et al. Evidence of estrone-sulfate uptake modification in young and middle-aged rat prostate. J Steroid Biochem Mol Biol 152, 89-100 (2015).